Mood response to methylphenidate in depressed patients on zimelidine

Upstream genetic variant near INSIG2, influences response to carnitine supplementation in bipolar patients with valproate-induced weight gain.

Acta neuropsychiatrica·2016

No change in neuropsychological dysfunction or emotional processing during treatment of major depression with cognitive-behaviour therapy or schema therapy.

Psychological medicine·2015

Five-year outcome of cognitive behavioral therapy and exposure with response prevention for bulimia nervosa.

Psychological medicine·2010

Measures of temperament and character are differentially impacted on by depression severity.

Journal of affective disorders·2010

A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants.

The pharmacogenomics journal·2010

Personality disorders improve in patients treated for major depression.

Acta psychiatrica Scandinavica·2009

Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Journal of clinical psychopharmacology·2026

Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.

Journal of clinical psychopharmacology·2026

Unintentional Lithium Toxicity in Patients With Bipolar Disorder: A Literature Review of Case Reports.

Journal of clinical psychopharmacology·2026

An Open-Label, Randomized, Active Controlled Trial Evaluating Sublingual Dexmedetomidine for Moderate to Severe Agitation in Inpatients With Schizophrenia or Bipolar Disorder.

Journal of clinical psychopharmacology·2026

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression.

Journal of clinical psychopharmacology·2026

Olanzapine/Samidorphan-Associated Opioid Withdrawal Reported to US Poison Centers.

Journal of clinical psychopharmacology·2026

Cell-specific cPGES control of glucocorticoid receptor function drives MASLD progression.

Cell reports·2026

1-Aminocyclopropane-1-Carboxylate and Its Chemoreceptor Drive Metabolic Reprogramming to Enhance Chemotactic Rhizocompetence in Pseudomonas sp. UW4.

Microorganisms·2026

From Solvent Design to Biological Response: Structure-Property Relationships of Edible Natural Deep Eutectic Solvents for the Extraction of Nigella sativa Bioactives.

Molecules (Basel, Switzerland)·2026

Molecular Characterization and RNAi-Based Functional Validation of Ache in the Neonicotinoid Stress Response of the Melon Fly, Zeugodacus cucurbitae.

Insects·2026

Enhancing materials discovery with valence-constrained design in generative modeling.

Nature computational science·2026

Autonomous bioisosteric replacement for multi-property optimization in drug design.

Nature communications·2026

Related Experiment Videos

Mood response to methylphenidate in depressed patients on zimelidine

Related Concept Videos

Upstream genetic variant near INSIG2, influences response to carnitine supplementation in bipolar patients with valproate-induced weight gain.

No change in neuropsychological dysfunction or emotional processing during treatment of major depression with cognitive-behaviour therapy or schema therapy.

Five-year outcome of cognitive behavioral therapy and exposure with response prevention for bulimia nervosa.

Measures of temperament and character are differentially impacted on by depression severity.

A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants.

Personality disorders improve in patients treated for major depression.

Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.

Unintentional Lithium Toxicity in Patients With Bipolar Disorder: A Literature Review of Case Reports.

An Open-Label, Randomized, Active Controlled Trial Evaluating Sublingual Dexmedetomidine for Moderate to Severe Agitation in Inpatients With Schizophrenia or Bipolar Disorder.

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression.

Olanzapine/Samidorphan-Associated Opioid Withdrawal Reported to US Poison Centers.

Cell-specific cPGES control of glucocorticoid receptor function drives MASLD progression.

1-Aminocyclopropane-1-Carboxylate and Its Chemoreceptor Drive Metabolic Reprogramming to Enhance Chemotactic Rhizocompetence in Pseudomonas sp. UW4.

From Solvent Design to Biological Response: Structure-Property Relationships of Edible Natural Deep Eutectic Solvents for the Extraction of Nigella sativa Bioactives.

Molecular Characterization and RNAi-Based Functional Validation of Ache in the Neonicotinoid Stress Response of the Melon Fly, Zeugodacus cucurbitae.

Enhancing materials discovery with valence-constrained design in generative modeling.

Autonomous bioisosteric replacement for multi-property optimization in drug design.

Related Experiment Videos

Mood response to methylphenidate in depressed patients on zimelidine

Related Concept Videos

Related Articles